RMC-4550

News alerts, weekly reports and conference planners

Company:

Revolution Medicines

Drug class:

PTPN11 inhibitor

Related drugs:

KRAS G12C	Lung Cancer	KRAS G12C	Lung Cancer	sotorasib + RMC-4550 Sensitive: D – Preclinical sotorasib + RMC-4550 Sensitive : D	sotorasib + RMC-4550 Sensitive: D – Preclinical sotorasib + RMC-4550 Sensitive : D
KRAS G12C	Non Small Cell Lung Cancer	KRAS G12C	Non Small Cell Lung Cancer	RMC-4550 + RM-029 Sensitive: D – Preclinical RMC-4550 + RM-029 Sensitive : D	RMC-4550 + RM-029 Sensitive: D – Preclinical RMC-4550 + RM-029 Sensitive : D

Associations
(2)